Skip to main content

Groundbreaking Begins!

We are thrilled to share that YMC America has officially broken ground on a significant expansion of our Devens, MA facility! This exciting project will increase our operational square footage by 50%, significantly boosting our U.S. manufacturing capabilities and paving the way for local job growth over the next decade.

A key highlight of this expansion is the enhanced ability to manufacture our state-of-the-art Dynamic Axial Compression (DAC) columns, designed to meet ASME and CE requirements, allowing for direct sales to our valued customers across the Americas and Europe.

As our President and CEO, Mark Dyment, stated, “This investment allows us to significantly enhance our manufacturing capacity and capabilities right here in the U.S. and provides the ability to sell directly to our local customers at a more cost-effective price. It positions us strongly for future growth and innovation.”

We were honored to have local contractors, dedicated DEC officials, including Director Neil Angus, and representatives from the Nashoba Chamber of Commerce join us for the groundbreaking ceremony on May 12th. A special thank you to our CEO, Mark Dyment, who recognized three of our exceptional employees, including Kathy Gregory and Aramis Jean-Louis, for their invaluable contributions to YMC America’s success, inviting them to join in the groundbreaking.

This expansion underscores our deep commitment to the Devens community and our excitement for future growth and innovation in U.S. manufacturing.

Posted on May 14, 2025.

Related Posts

September 4, 2026

YMC America Brings U.S.-Supplied ASME U-Stamped DAC Columns to Pharmaceutical Manufacturers

YMC America will be the First U.S.-Based Supplier of ASME U-Stamped DAC Columns. The company’s DAC columns support pharmaceutical and biopharmaceutical customers from process development through commercial production. Systems are used in laboratory, pilot, and production-scale chromatography applications, including purification processes for peptides, oligonucleotides, and small-molecule APIs.

September 10, 2026

Analytical Technologies for Therapeutic Peptides

Therapeutic peptides are an emerging class of active pharmaceutical ingredients that, together with other classes of bioproducts, have been attracting considerable attention due to their unique advantages. Their structure is based on well-defined amino acid sequences that may or may not contain structural modifications, resulting in molecules that generally range from 500 to 5000 Da. Currently, many examples can be used as medicines related to hormones, growth factors, neurotransmitters, among others.

September 9, 2026

Tecnologias Analíticas para Peptídeos Terapêuticos- Portuguese

Os peptídeos terapêuticos são uma classe emergente de insumos farmacêuticos ativos que, juntamente com outras classes de bioprodutos, vêm despertando grande interesse devido às suas vantagens únicas.

Designed and developed by